Skip to main content

Natus Medical Incorporated Value Stock - Dividend - Research Selection

Natus Medical Incorporated

ISIN: US6390501038, WKN: 578916

Market price date: 27.05.2021
Market price: 26,60 USD

Natus Medical Incorporated Fundamental data and company key figures of the share

Annual reports in USD
Key figures 02-03-2021
Cash flow
Net operating cash flow 34.426.000
Capital Expenditures -8.609.000
Free cash flow 25.817.000
Balance sheet
Total Equity 411.094.000
Liabilities & Shareholders equity 600.394.000
Income statement
Net income -16.613.000
Eps (diluted) -0,490
Diluted shares outstanding 33.911.700
Net sales/revenue 415.684.000

Fundamental ratios calculated on: 27-05-2021

Key figures 27-05-2021
Cash flow
P/C 26,73
P/FC 34,94
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization920.024.448,00 USD
IndicesNASDAQ Comp.
Raw Data SourceUS GAAP in Millionen USD
Stock Split

Description of the company

Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company´s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn´s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus categorizes its products into three categories: Hearing, Neurology and Newborn Care. In July 2012, the Company acquired the Nicolet neurodiagnostic business from CareFusion.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,